BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Mar 27, 2025; 17(3): 103807
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103807
Hypochloremia is an underutilised prognostic marker in patients with advanced liver cirrhosis and liver failure
Jinit R Soni, Sudheer Marrapu, Ramesh Kumar
Jinit R Soni, Sudheer Marrapu, Ramesh Kumar, Department of Gastroenterology, All India Institute of Medical Sciences, Patna 801507, India
Author contributions: Soni JR and Kumar R designed the concept, collected the data and wrote the manuscript research study; Marrapu S collected the data and wrote the manuscript; All authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Ramesh Kumar, MD, Department of Gastroenterology, All India Institute of Medical Sciences, Phulwari Sharif, Patna 801507, India. docrameshkr@gmail.com
Received: December 2, 2024
Revised: February 16, 2025
Accepted: February 27, 2025
Published online: March 27, 2025
Processing time: 115 Days and 14.7 Hours
Core Tip

Core Tip: Patients with advanced liver cirrhosis and liver failure frequently experience abnormalities in their serum electrolyte levels. Emerging evidence suggests that serum chloride may provide prognostic information in such patients. Hypochloremia has been associated with higher mortality, worsened liver dysfunction, and a greater need for vasopressors and renal replacement therapy. Despite its prognostic significance, serum chloride is often overshadowed by other electrolytes. Notwithstanding the limited available evidence, we believe that serum chloride is an underutilised prognostic marker in clinical practice. Thus, this article aims to elucidate the prognostic significance of lower serum chloride levels in patients with advanced liver disease.